Sleep
Sleep, licence 80142930: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Plexus Sleep
- Licence holder
- Plexus Canada Limited Partnership dba Plexus Worldwide
- NPN or DIN-HM
- 80142930
- Status
- Active licence
- Licence date
- 24 July 2025
- Revision date
- Not provided
- Form
- Bloc
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| L-Tryptophane Source : L-Tryptophane | 5.0 mg | Not calculated |
| Melissa officinalis Source : Melissa officinalis - Herb top Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 4 mg | 1.0 mg | Not calculated |
| Acide 4-aminobutanoïque Source : gamma-Aminobutyric acid | 10.0 mg | Not calculated |
| N-Acétyl-5-méthoxytryptamine Source : Mélatonine | 5.0 mg | Not calculated |
| Fructooligosaccharides Source : Cichorium intybus - racine | 1.7 g | Not calculated |
| Fructooligosaccharides Source : Saccharum officinarum - Stem | 1.7 g | Not calculated |
| Withania somnifera Source : Withania somnifera - racine Potency : 0.4 % Withanolide glycosides | 62.5 mg | Not calculated |
Non-medicinal ingredients
Extrait de feuilles de stévia, Saveur de citron, Acide D-malique, Fécule de manioc, Saveur de fraises mélangées, Huile de noix de coco, Cire de Carnauba, NA, Pectine, Eau purifiée, Concentré du jus de fruit de Vaccinium corymbosum, Saveur de sucrose, Acide citrique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18.0 ans | 1.0 Bloc | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
(Used as a) sleep aid (to help promote sleep). Helps (to) prevent and/or reduce the effects of jet lag/minimize jet lag (e.g. daytime fatigue, sleep disturbance) (for people/if travelling by plane easterly across two or more time zones/flying east over two or more time zones) Helps (to) re-set the body’s sleep-wake cycle (aspect of the circadian rhythm). Helps (to) speed up/reduce the time it takes to fall asleep (sleep onset latency aspect of sleep quality) in people who fall asleep slowly/with delayed sleep phase disorder. Helps increase the total sleep time (aspect of sleep quality) in people suffering from sleep restriction or altered sleep schedule (e.g. shift-work and jet lag).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80142930
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.